036sek
-13,6 %
Date:2024-07-24Time:17:29:00Latest report:Q1-2024List:SpotlightTicker:PEXA B
Market Cap:21 msekEnterprise Value:13 msekNet Sales:1,84 msekEarnings:-8,11 msekEmployees:0ISIN:SE0007412374

Ratios

10-year key figure history for PExA turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for PExA with index and moving average MA50 and MA200.

Stockprice:0,36
MA50:0,40
MA200:0,44
Price/MA200:-16,8 %
RSI (14):44,7
Price/MA50:-8,8 %

Description

PExA has developed a patented research instrument - PExA 2.0 - to study respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). PExA currently provides lung researchers with a simple, harmless and painless method for collecting microscopic liquid droplets in exhaled air that contains potential biomarkers for diseases of the small airways. Through the method, the researchers have easy access to a sample from the liquid layer that covers the smallest airways, which competing methods do not reach. The test can be compared to a blood test for the small airways and can be used to detect lung diseases at an early stage. The purpose is to facilitate research and development of reliable and individualized diagnosis, monitoring and treatment of respiratory diseases.

Medical Equipment